Barry E. Greene
2010 - Alnylam Pharmaceuticals
In 2010, Barry E. Greene earned a total compensation of $939.6K as President and Chief Operating Officer at Alnylam Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $50,895 |
|---|---|
| Option Awards | $485,130 |
| Salary | $390,000 |
| Other | $13,539 |
| Total | $939,564 |
Greene received $485.1K in option awards, accounting for 52% of the total pay in 2010.
Greene also received $50.9K in non-equity incentive plan, $390K in salary and $13.5K in other compensation.
Rankings
In 2010, Barry E. Greene's compensation ranked 5,534th out of 10,439 executives tracked by ExecPay. In other words, Greene earned more than 47.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,534 out of 10,439 | 47th |
Division Manufacturing | 2,001 out of 3,838 | 48th |
Major group Chemicals And Allied Products | 427 out of 921 | 54th |
Industry group Drugs | 257 out of 680 | 62nd |
Industry Pharmaceutical Preparations | 190 out of 481 | 61st |
Source: SEC filing on May 2, 2011.
Greene's colleagues
We found five more compensation records of executives who worked with Barry E. Greene at Alnylam Pharmaceuticals in 2010.
2010
Laurence Reid
Alnylam Pharmaceuticals
Senior Vice President and Chief Business Officer
2010
Kenneth Koblan
Alnylam Pharmaceuticals
Chief Scientific Officer
2010
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2010
Akshay Vaishnaw
Alnylam Pharmaceuticals
Senior Vice President, Clinical Research
2010
Patricia Allen
Alnylam Pharmaceuticals